Page 198 - Read Online

Page 10 of 10 Zhao et al. Mini-invasive Surg 2018;2:26 I http://dx.doi.org/10.20517/2574-1225.2018.27

tumors: does it have a role in local tumor control? J Vasc Interv Radiol 2008;19:706-11.
6. Lanuti M, Sharma A, Willers H, Digumarthy SR, Mathisen DJ, Shepard JA. Radiofrequency ablation for stage I non-small cell lung
cancer: management of locoregional recurrence. Ann Thorac Surg 2012;93:921-7.
7. Yang X, Ye X, Huang G, Han X, Wang J, Li W, Wei Z, Meng M. Repeated percutaneous microwave ablation for local recurrence of in-
operable stage I nonsmall cell lung cancer. J Cancer Res Ther 2017;13:683-8.
8. National Cancer Institute. Common Terminology Criteria for Adverse Events, version 4.03. Available from: https://www.eortc.be/ser-
vices/doc/ctc/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. [Last accessed on 17 Aug 2018]
9. de Baère T, Aupérin A, Deschamps F, Chevallier P, Gaubert Y, Boige V, Fonck M, Escudier B, Palussiére J. Radiofrequency ablation is a
valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol 2015;26:987-91.
10. StataCorp. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC 2017.
11. Splatt AM, Steinke K. Major complications of high-energy microwave ablation for percutaneous CT-guided treatment of lung malignan-
cies: single-centre experience after 4 years. J Med Imaging Radiat Oncol 2015;59:609-16.
12. Schoellnast H, Deodhar A, Hsu M, Moskowitz C, Nehmeh SA, Thornton RH, Sofocleous CT, Alago W Jr, Downey RJ, Azzoli CG,
Rosenzweig KE, Solomon SB. Recurrent non-small cell lung cancer: evaluation of CT-guided radiofrequency ablation as salvage thera-
py. Acta Radiol 2012;53:893-9.
13. Von Meyenfeldt EM, Prevoo W, Peyrot D, Lai A Fat N, Burgers SJ, Wouters MW, Klomp HM. Local progression after radiofrequency
ablation for pulmonary metastases. Cancer 2011;117:3781-7.
14. Gillams A, Khan Z, Osborn P, Lees W. Survival after radiofrequency ablation in 122 patients with inoperable colorectal lung metastases.
Cardiovasc Intervent Radiol 2013;36:724-30.
15. Yang X, Ye X, Zheng A, Huang G, Ni X, Wang J, Han X, Li W, Wei Z. Percutaneous microwave ablation of stage I medically inoper-
able non-small cell lung cancer: Clinical evaluation of 47 cases. J Surg Oncol 2014;110:758-63.
16. Steinke K, Glenn D, King J, Clark W, Zhao J, Clingan P, Morris DL. Percutaneous imaging-guided radiofrequency ablation in patients
with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol 2004;11:207-12.
17. Acksteiner C, Steinke K. Percutaneous microwave ablation for early-stage non-small cell lung cancer (NSCLC) in the elderly: a promis-
ing outlook. J Med Imaging Radiat Oncol 2015;59:82-90.
18. Liu H, Steinke K. High-powered percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: a pre-
liminary study. J Med Imaging Radiat Oncol 2013;57:466-74.
19. Huang L, Han Y, Zhao J, Wang X, Cheng Q, Li X, Xu H, Gao K. Is radiofrequency thermal ablation a safe and effective procedure in
the treatment of pulmonary malignancies? Eur J Cardiothorac Surg 2011;39:348-51.
20. Sofocleous CT, Sideras P, Petre EN, Solomon SB. Ablation for the management of pulmonary malignancies. AJR Am J Roentgenol
2011;197:W581-9.
21. McLoney ED, Isaacson AJ, Keating P. The role of PET imaging before, during, and after percutaneous hepatic and pulmonary tumor
ablation. Semin Intervent Radiol 2014;31:187-92.
22. Yoo DC, Dupuy DE, Hillman SL, Fernando HC, Rilling WS, Shepard JA, Siegel BA. Radiofrequency ablation of medically inoper-
able stage IA non-small cell lung cancer: are early posttreatment pet findings predictive of treatment outcome? AJR Am J Roentgenol
2011;197:334-40.
23. Zaheer SN, Whitley JM, Thomas PA, Steinke K. Would you bet on PET? Evaluation of the significance of positive PET scan results
post-microwave ablation for non-small cell lung cancer. J Med Imaging Radiat Oncol 2015;59:702-12.
24. Higuchi M, Suzuki H, Gotoh M. Role of PET/computed tomography in radiofrequency ablation for malignant pulmonary tumors. PET
Clin 2016;11:47-55.